Trademark: 90083614
Status Date
Monday, November 21, 2022
Filing Date
Thursday, July 30, 2020
Published for Opposition
Tuesday, February 23, 2021
Abandoned Date
Monday, November 21, 2022
40 Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
5 Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
35 Advertising services; personnel management consultancy; accounting services; business management assistance; sponsorship search; Retail or wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; provision of an on-line marketplace for buyers and sellers of goods and services; systemization of information into computer databases
44 Telemedicine services; health care; convalescent home services; beauty salon services; physical therapy services; gardening; veterinary services; health counseling; pharmacy advice, namely, pharmaceutical advice; rental of sanitary installations
42 Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
The mark consists of a square design, within the square is a diamond within another stylized diamond.
Nov 21, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 21, 2022
Abandonment - No Use Statement Filed
Apr 7, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2022
Sou Extension 2 Granted
Apr 5, 2022
Sou Extension 2 Filed
Apr 5, 2022
Teas Extension Received
Oct 20, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 18, 2021
Sou Extension 1 Granted
Oct 18, 2021
Sou Extension 1 Filed
Oct 18, 2021
Teas Extension Received
Apr 20, 2021
Noa E-Mailed - Sou Required From Applicant
Feb 23, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 23, 2021
Published For Opposition
Feb 3, 2021
Notification Of Notice Of Publication E-Mailed
Jan 28, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 28, 2021
Teas Change Of Correspondence Received
Jan 28, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 28, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 28, 2021
Teas Change Of Owner Address Received
Jan 15, 2021
Approved For Pub - Principal Register
Jan 15, 2021
Examiner's Amendment Entered
Jan 15, 2021
Notification Of Examiners Amendment E-Mailed
Jan 15, 2021
Examiners Amendment E-Mailed
Jan 15, 2021
Examiners Amendment -Written
Jan 6, 2021
Teas/Email Correspondence Entered
Jan 6, 2021
Correspondence Received In Law Office
Jan 6, 2021
Teas Response To Office Action Received
Nov 6, 2020
Notification Of Non-Final Action E-Mailed
Nov 6, 2020
Non-Final Action E-Mailed
Nov 6, 2020
Non-Final Action Written
Nov 5, 2020
Assigned To Examiner
Aug 29, 2020
Notice Of Design Search Code E-Mailed
Aug 28, 2020
New Application Office Supplied Data Entered In Tram
Aug 3, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
